162 related articles for article (PubMed ID: 27474920)
1. Synthesis, X-ray crystal structure and anti-tumor activity of calix[n]arene polyhydroxyamine derivatives.
An L; Han LL; Zheng YG; Peng XN; Xue YS; Gu XK; Sun J; Yan CG
Eur J Med Chem; 2016 Nov; 123():21-30. PubMed ID: 27474920
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of calix[4]arene-based carbonyl amide derivatives with antitumor activities.
An L; Wang C; Zheng YG; Liu JD; Huang TH
Eur J Med Chem; 2021 Jan; 210():112984. PubMed ID: 33183867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Crystal Structure, and Biological Activity of a Multidentate Calix[4]arene Ligand Doubly Functionalized by 2-Hydroxybenzeledene-Thiosemicarbazone.
Bahojb Noruzi E; Shaabani B; Geremia S; Hickey N; Nitti P; Kafil HS
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963211
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the Anticancer Activity of Chlorambucil and Ibuprofen via Calix[4]arene Conjugates.
Pedro-Hernández LD; Organista-Mateos U; Allende-Alarcón LI; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M
Med Chem; 2020; 16(7):984-990. PubMed ID: 31448714
[TBL] [Abstract][Full Text] [Related]
5. Structural Design, Synthesis, and Preliminary Biological Evaluation of Novel Dihomooxacalix[4]arene-Based Anti-tumor Agents.
An L; Wang C; Han L; Liu J; Huang T; Zheng Y; Yan C; Sun J
Front Chem; 2019; 7():856. PubMed ID: 31921778
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Anticancer Activities of Novel Facile Synthesized Calix[n]arene Sulfonamide Analogs.
Yilmaz B; Bayrac AT; Bayrakci M
Appl Biochem Biotechnol; 2020 Apr; 190(4):1484-1497. PubMed ID: 31782087
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity evaluation of novel azacalix[2]arene[2]pyrimidines.
Addepalli Y; Yang X; Zhou M; Reddy DP; Zhang SL; Wang Z; He Y
Eur J Med Chem; 2018 May; 151():214-225. PubMed ID: 29614418
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of the antitumor activity of Calix[4]arene l-proline derivatives.
Oguz M; Gul A; Karakurt S; Yilmaz M
Bioorg Chem; 2020 Jan; 94():103207. PubMed ID: 31451296
[TBL] [Abstract][Full Text] [Related]
9. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure, and reactions of NH-bridged calix[m]arene[n]pyridines.
Yao B; Wang DX; Gong HY; Huang ZT; Wang MX
J Org Chem; 2009 Aug; 74(15):5361-8. PubMed ID: 19496575
[TBL] [Abstract][Full Text] [Related]
11. Selective functionalization of a single methylene bridge of a calix[6]arene.
Itzhak N; Biali SE
J Org Chem; 2010 May; 75(10):3437-42. PubMed ID: 20420399
[TBL] [Abstract][Full Text] [Related]
12. Arene ruthenium complexes as anticancer agents.
Süss-Fink G
Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
[TBL] [Abstract][Full Text] [Related]
13. Cytostatic/cytotoxic effects of 5-fluorouridine nucleolipids on colon, hepatocellular, and renal carcinoma cells: in vitro identification of a potential cytotoxic multi-anticancer drug.
Farhat A; Malecki E; Bonaterra GA; Röthlein D; Wolf M; Schmitt J; Rosemeyer H; Kinscherf R
Chem Biodivers; 2014 Mar; 11(3):469-82. PubMed ID: 24634076
[TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted synthesis of arene ruthenium(II) complexes that induce S-phase arrest in cancer cells by DNA damage-mediated p53 phosphorylation.
Wu Q; Fan C; Chen T; Liu C; Mei W; Chen S; Wang B; Chen Y; Zheng W
Eur J Med Chem; 2013 May; 63():57-63. PubMed ID: 23455057
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
16. FURIN INHIBITORS BASED ON THE DERIVATIVES OF CALIX[4]ARENE CX3im.
Kibirev VK; Osadchuk TV; Rodik RV; Kalchenko VI
Ukr Biochem J; 2015; 87(3):31-6. PubMed ID: 26502697
[TBL] [Abstract][Full Text] [Related]
17. Calix[4]API-s: fully functionalized calix[4]arene-based facial active pharmaceutical ingredients.
Pur FN
Mol Divers; 2021 May; 25(2):1247-1258. PubMed ID: 32006298
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.
Zhou H; Wang DA; Baldini L; Ennis E; Jain R; Carie A; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Jun; 4(12):2376-86. PubMed ID: 16763682
[TBL] [Abstract][Full Text] [Related]
19. The new 5- or 6-azapyrimidine and cyanuric acid derivatives of l-ascorbic acid bearing the free C-5 hydroxy or C-4 amino group at the ethylenic spacer: CD-spectral absolute configuration determination and biological activity evaluations.
Wittine K; Babić MS; Košutić M; Cetina M; Rissanen K; Pavelić SK; Paravić AT; Sedić M; Pavelić K; Mintas M
Eur J Med Chem; 2011 Jul; 46(7):2770-85. PubMed ID: 21524828
[TBL] [Abstract][Full Text] [Related]
20. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
